Lim, Sean H. and Johnson, Peter W.M.
Chemotherapy: advanced Hodgkin lymphoma - balancing toxicity and cure
Nature Reviews Clinical Oncology, 8, (11), . (doi:10.1038/nrclinonc.2011.137). (PMID:21894205).
Full text not available from this repository.
The combination of doxorubicin, bleomycin, vincristine and dacarbazine (ABVD) has emerged as a standard of care in advanced-stage Hodgkin lymphoma over the past four decades. Clinicians treating patients with cancer frequently walk a tightrope where the requirements of efficacy have to be balanced against the morbidity caused by the treatment.
Actions (login required)